Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Psychiatry/Psychology | Family Medicine
Disease Category: Dementia
Location: United States, CA
Mild Cognitive Impairment
This study will investigate the potential treatment effects of IVIG (intravenous immunoglobulin) to target early Alzheimer's Disease in persons with MCI. MRI brain imaging and cognitive testing will be conducted over approximately 2 years.
Patient Inclusion Criteria:
Below are some of the exclusionary criteria that will exclude a subject from being enrolled into the study:
CW ID: 172585
Date Last Changed:
July 22, 2013
Tammy Donnel, Clinical Research CoordinatorSutter Institute for Medical Research (SIMR)2801 Capitol Avenue
Suite 210Sacramento, CA 95816Phone: 916-453-5994Fax: 916-733-8968
Sutter Institute for Medical Research (SIMR)
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.